Evidence map›Paper›PMID 25069772›Full record

ArticleThe EMBO journal2014

Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion.

Cameron P Bracken, Xiaochun Li, Josephine A Wright, David M Lawrence, Katherine A Pillman, Marika Salmanidis, Matthew A Anderson, B Kate Dredge, Philip A Gregory, Anna Tsykin and 8 more

Abstract read
In one paragraph

Article in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 135 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Cameron P BrackenCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
Xiaochun LiCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Josephine A WrightCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
David M LawrenceCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Katherine A PillmanCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Marika SalmanidisCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Matthew A AndersonCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
B Kate DredgeSchool of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA, Australia.
Philip A GregoryCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
Anna TsykinCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Corine NeilsenCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Daniel W ThomsonCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Andrew G BertCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
Joanne M LeerbergDivision of Molecular Cell Biology, Institute for Molecular Bioscience University of Queensland, St Lucia, Brisbane, Qld, Australia.
Alpha S YapDivision of Molecular Cell Biology, Institute for Molecular Bioscience University of Queensland, St Lucia, Brisbane, Qld, Australia.
Kirk B JensenSchool of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA, Australia.
Yeesim Khew-GoodallCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA, Australia yeesim.khew-goodall@health.sa.gov.au greg.goodall@health.sa.gov.au.
Gregory J GoodallCentre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA, Australia yeesim.khew-goodall@health.sa.gov.au greg.goodall@health.sa.gov.au.
South Australia Pathology · AUCentre for Cancer Biology · AUUniversity of Adelaide · AUUniversity of South Australia · AUUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microRNAs of the miR-200 family maintain the central characteristics of epithelia and inhibit tumor cell motility and invasiveness. Using the Ago-HITS-CLIP technology for transcriptome-wide identification of direct microRNA targets in living cells, along with extensive validation to verify the reliability of the approach, we have identified hundreds of miR-200a and miR-200b targets, providing insights into general features of miRNA target site selection. Gene ontology analysis revealed a predominant effect of miR-200 targets in widespread coordinate control of actin cytoskeleton dynamics. Functional characterization of the miR-200 targets indicates that they constitute subnetworks that underlie the ability of cancer cells to migrate and invade, including coordinate effects on Rho-ROCK signaling, invadopodia formation, MMP activity, and focal adhesions. Thus, the miR-200 family maintains the central characteristics of the epithelial phenotype by acting on numerous targets at multiple levels, encompassing both cytoskeletal effectors that control actin filament organization and dynamics, and upstream signals that locally regulate the cytoskeleton to maintain cell morphology and prevent cell migration.

Indexed as

Cell MovementCell ProliferationGene Expression RegulationGene Regulatory NetworksCell LineCytoskeletonEpithelial CellsHumansMicroRNAsMicroRNAsMIRN200 microRNA, humancytoskeletonHITS‐CLIPinvadopodiamicroRNAmiR‐200

Identifiers

PMID25069772
PMCPMC4195771
OpenAlexW2143207688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.